Macro monthly | The two track recovery | Article – HSBC VisionGo
- The US continues to lead the global recovery and the European outlook is improving too…
- …India looks to have contained its second wave, but variants are spreading through ASEAN
- While some central banks are tightening, others are signalling their desire to keep policy loose
The two track recovery across the world is continuing as developed markets with impressive vaccine rollouts are removing restrictions and reopening their economies. Consumers appear ready to get out of the house and start spending on services – evident in the US data and this trend is likely to spread into Europe in the coming months. Conversely, in other parts of the world, notably in Asia, with surging case numbers and lower vaccine numbers, restrictions are tightening.
Mobility data is improving in Europe; India is recovering
European mobility data has seen a meaningful pick-up in recent months, while encouragingly, India has seen new cases and deaths from COVID-19 plummet, and our economic recovery tracker is back to near pre-pandemic levels. But different variants are continuing to advance through ASEAN and LatAm, as well as the UK. However, the UK has reopened as planned as nearly 50% of people are now fully vaccinated and hospitalisations are thankfully still relatively low.
Worker shortages are being felt in leisure and hospitality
Job market in focus
As parts of the developed world emerge from restrictions, attention turns to labour markets, where worker shortages are causing havoc for employers, particularly within leisure and hospitality. Wages in the sector are rising quickly as a result.
In the US, we are seeing the number of people quitting jobs rising, suggesting that workers are feeling more confident in their prospects. Many office workers, particularly young people, want to work from home either full time or at least part time (source: Citrix) and with a large surplus of job openings, employees are exploring their options. A big question mark still hangs over how labour markets will evolve as job support schemes are withdrawn.
Meanwhile, the relatively weak labour market and slightly stretched household balance sheets in mainland China are delaying its consumption recovery. The surveyed unemployment rate has fallen back to the pre-pandemic level, but youth unemployment remains high (source: CEIC).
We still expect elevated inflation to be transitory
Inflation still elevated
Inflation is elevated around the world as supply bottlenecks, shipping disruptions, and surging demand drive up prices. Higher commodity prices and base effects are also lifting headline inflation prints. We still expect this to prove transitory and look for inflation to moderate in 2022. However, heightened prices and post-lockdown booms have forced some central banks to act.
Many G10 central banks look to be keeping rates on hold
Central bank response
Central banks in Brazil, Mexico, Russia, and parts of Central and Eastern Europe have already started tightening, but others across the world are willing to wait. The Fed may have begun discussions on how and when tapering might begin, but a rate rise is still set to be two years away, while many other G10 central banks show little sign of raising rates any time soon (Chart 3), even though house prices keep going up. The People’s Bank of China, however, recently cut the required reserve ratio by 0.5%, aimed at providing funding to small-and-medium sized enterprises, which account for over 85% of employment (source: CEIC).
This document is for information purposes only and should not be regarded as an offer to sell or as a solicitation of an offer to buy the securities or other investment products mentioned in it and/or to participate in any trading strategy. Information in this document is general and should not be construed as investment advice, given it has been prepared without taking account of the objectives, financial situation or needs of any particular investor. Accordingly, investors should, before acting on it, consider the appropriateness of the information, having regard to their objectives, financial situation and needs and, if necessary, seek professional investment and tax advice.
Certain investment products mentioned in this document may not be eligible for sale in some states or countries, and they may not be suitable for all types of investors. Investors should consult with their HSBC representative regarding the suitability of the investment products mentioned in this document and take into account their specific investment objectives, financial situation or particular needs before making a commitment to purchase investment products.
The value of and the income produced by the investment products mentioned in this document may fluctuate, so that an investor may get back less than originally invested. Certain high-volatility investments can be subject to sudden and large falls in value that could equal or exceed the amount invested. Value and income from investment products may be adversely affected by exchange rates, interest rates, or other factors. Past performance of a particular investment product is not indicative of future results.
HSBC and its affiliates will from time to time sell to and buy from customers the securities/instruments (including derivatives) of companies covered here on a principal or agency basis.
Whether, or in what time frame, an update of this information will be published is not determined in advance.
This report is dated as at 29 July 2021.
All market data included in this report are dated as at close 27 July 2021, unless a different date and/or a specific time of day is indicated in the report.
HSBC has procedures in place to identify and manage any potential conflicts of interest that arise in connection with its Research business. HSBC's analysts and its other staff who are involved in the preparation and dissemination of Research operate and have a management reporting line independent of HSBC's Investment Banking business. Information Barrier procedures are in place between the Investment Banking, Principal Trading, and Research businesses to ensure that any confidential and/or price sensitive information is handled in an appropriate manner.
You are not permitted to use, for reference, any data in this document for the purpose of (i) determining the interest payable, or other sums due, under loan agreements or under other financial contracts or instruments, (ii) determining the price at which a financial instrument may be bought or sold or traded or redeemed, or the value of a financial instrument, and/or (iii) measuring the performance of a financial instrument or of an investment fund.